Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD

2018; Elsevier BV; Volume: 131; Issue: 25 Linguagem: Inglês

10.1182/blood-2018-01-822957

ISSN

1528-0020

Autores

Hannah Major-Monfried, Anne S. Renteria, Attaphol Pawarode, Pavan Reddy, Francis Ayuk, Ernst Holler, Yvonne A. Efebera, William J. Hogan, Matthias Wölfl, Muna Qayed, Elizabeth O. Hexner, Kitsada Wudhikarn, Rainer Ordemann, Rachel Young, Jay Shah, Matthew J. Hartwell, Mohammed S. Chaudhry, Mina Aziz, Aaron Etra, Gregory A. Yanik, Nicolaus Kröger, Daniela Weber, Yi‐Bin Chen, Ryotaro Nakamura, Wolf Rösler, Carrie L. Kitko, Andrew C. Harris, Michael A. Pulsipher, Ran Reshef, Steven Kowalyk, George Morales, I.M. Torres, Umut Özbek, James L.M. Ferrara, John E. Levine,

Tópico(s)

Inflammatory Biomarkers in Disease Prognosis

Resumo

Key Points Biomarker scores generated after 1 week of steroid treatment of GVHD are prognostic. Biomarkers reflect prognosis better than early clinical response to GVHD treatment.

Referência(s)